On the other hand, potential therapeutic benefits of increasing ACE2 expression or activity using recombinant human ACE2, gene therapy, or ACE2 activators has been shown to be effective in several diseases including hypertension, heart failure, stroke, diabetes, and kidney injury [1,4,5,6]. The gene discussed is ACE2; the disease is heart failure.